More than nine out of 10 scientists who backed a drug at the centre of a safety scare had financial links to the pharmaceutical industry, a study has found.
The disclosure will renew concern about the influence of the multinational companies on patient safety, where a warning about a drug can wipe billions from their balance sheets.
The pharmaceutical industry has become adept at manipulating results and selectively withholding unfavourable data that could expose patients to harm. Now it is accused of skewing the debate over one drug, Avandia, prescribed to millions of people around the world with Type 2 diabetes. Avandia, made by the British multinational GlaxoSmithKline (GSK), which helps diabetics control their blood sugar levels, was linked with an increased risk of heart attacks in research published in 2007.
When abortion restrictions are in the news, as they have been for several weeks, research shows...
Congolese authorities say that suspected Ebola cases have now passed 900 in the ongoing outbreak in...
By the time the American surgeon who contracted Ebola in Congo was flown to Germany for...
